International Peer-Reviewed JournalOpen AccessISSN 2456-8880
irejournals@gmail.com+91-7433024337

Home / Current Issue / Paper 1710570

1710570 Vol 3 · Issue 8 Download Paper

Strengthening Patient Safety Protocols Through Data Integrity and Adverse Event Management

Chisom Ezeanochie Opeoluwa Oluwanifemi Ajayi Christiana Adeyemi

Subject area: Biological & Medical Sciences  ·  Area of research: Patient Safety

Abstract

Patient safety remains a cornerstone of effective healthcare delivery, yet it continues to face significant challenges due to lapses in data integrity and inadequate adverse event management systems. Ensuring accurate, complete, and reliable health data is critical to minimizing medical errors, optimizing clinical decision-making, and safeguarding patient outcomes. This study explores how strengthening patient safety protocols through robust data integrity measures and comprehensive adverse event management frameworks can transform healthcare systems. The paper emphasizes the role of advanced health information technologies, including electronic health records (EHRs), predictive analytics, and artificial intelligence, in enhancing data accuracy, preventing duplication, and ensuring real-time monitoring of patient conditions. By integrating these tools with standardized reporting systems, healthcare organizations can better detect, document, and respond to adverse events such as medication errors, hospital-acquired infections, and surgical complications. The research also highlights the importance of establishing a culture of transparency, continuous learning, and accountability in healthcare institutions, where frontline staff are encouraged to report safety concerns without fear of blame. Furthermore, the paper underscores the need for regulatory compliance with global patient safety frameworks, data protection laws, and interoperability standards to ensure consistency across diverse healthcare settings. Case examples demonstrate how improved data governance and adverse event surveillance can reduce preventable harm, shorten hospital stays, and lower healthcare costs. The findings suggest that a multi-pronged approach combining technology adoption, staff training, policy development, and stakeholder collaboration is essential to strengthening patient safety. Ultimately, advancing data integrity and adverse event management will not only protect patients but also build public trust, support sustainable healthcare delivery, and align with global health priorities such as the World Health Organization?s Patient Safety Action Plan. This work contributes to ongoing discourse on healthcare quality improvement by presenting an integrated framework for safeguarding patients through data-driven safety protocols.

Keywords

Patient Safety, Data Integrity, Adverse Event Management, Electronic Health Records, Predictive Analytics, Healthcare Quality, Patient Outcomes, Medical Errors, Data Governance, Risk Management

References

[1] Adelusi, B. S., Uzoka, A. C., Goodness, Y., & Hassan, F. U. O. (2020). Leveraging Transformer-Based Large Language Models for Parametric Estimation of Cost and Schedule in Agile Software Development Projects.

[2] Agrafiotis, D. K., Lobanov, V. S., Farnum, M. A., Yang, E., Ciervo, J., Walega, M., ... & Mackey, A. J. (2018). Risk-based monitoring of clinical trials: an integrative approach. Clinical therapeutics, 40(7), 1204-1212.

[3] Akpan, U. U., Adekoya, K. O., Awe, E. T., Garba, N., Oguncoker, G. D., & Ojo, S. G. (2017). Mini-STRs screening of 12 relatives of Hausa origin in northern Nigeria. Nigerian Journal of Basic and Applied Sciences, 25(1), 48-57.

[4] Akpan, U. U., Awe, T. E., & Idowu, D. (2019). Types and frequency of fingerprint minutiae in individuals of Igbo and Yoruba ethnic groups of Nigeria. Ruhuna Journal of Science, 10(1).

[5] Alemayehu, C., Mitchell, G., & Nikles, J. (2018). Barriers for conducting clinical trials in developing countries-a systematic review. International journal for equity in health, 17(1), 37.

[6] Alsulami, S. A., & Sherwood, G. (2020). The experience of culturally diverse faculty in academic environments: A multi-country scoping review. Nurse Education in Practice, 44, 102777.

[7] Armstrong, A. W., Watson, A. J., Makredes, M., Frangos, J. E., Kimball, A. B., & Kvedar, J. C. (2009). Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring. Archives of dermatology, 145(11), 1230-1236.

[8] Arora, N., Maurya, P. K., & Kacker, P. (2017). Translational research in drug discovery and development. In Translational Bioinformatics and Its Application (pp. 55-87). Dordrecht: Springer Netherlands.

[9] Atobatele, O. K., Hungbo, A. Q., & Adeyemi, C. (2019). Digital Health Technologies and Real-Time Surveillance Systems: Transforming Public Health Emergency Preparedness Through Data-Driven Decision Making.

[10] Atobatele, O. K., Hungbo, A. Q., & Adeyemi, C. (2019). Evaluating the Strategic Role of Economic Research in Supporting Financial Policy Decisions and Market Performance Metrics.

[11] Atobatele, O. K., Hungbo, A. Q., & Adeyemi, C. (2019). Leveraging Big Data Analytics for Population Health Management: A Comparative Analysis of Predictive Modeling Approaches in Chronic Disease Prevention and Healthcare Resource Optimization.

[12] Awe, E. T. (2017). Hybridization of snout mouth deformed and normal mouth African catfish Clarias gariepinus. Animal Research International, 14(3), 2804-2808.

[13] Awe, E. T., & Akpan, U. U. (2017). Cytological study of Allium cepa and Allium sativum.

[14] Awe, E. T., Akpan, U. U., & Adekoya, K. O. (2017). Evaluation of two MiniSTR loci mutation events in five Father-Mother-Child trios of Yoruba origin. Nigerian Journal of Biotechnology, 33, 120-124.

[15] Bankole, A. O., Nwokediegwu, Z. S., & Okiye, S. E. (2020). Emerging cementitious composites for 3D printed interiors and exteriors: A materials innovation review. Journal of Frontiers in Multidisciplinary Research, 1(1), 127–144. ISSN: 3050-9726

[16] Barger, S., Sullivan, S. D., Bell-Brown, A., Bott, B., Ciccarella, A. M., Golenski, J., ... & Ramsey, S. D. (2019). Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care. BMC Medical Research Methodology, 19(1), 119.

[17] Beck, D., Asghar, A., Kenworthy-Heinige, T., Johnson, M. R., Willis, C., Kantorowicz, A. S., ... & DeLue, C. (2020). Increasing access to clinical research using an innovative mobile recruitment approach: the (MoRe) concept. Contemporary clinical trials communications, 19, 100623.

[18] Bhatt, A. (2011). Quality of clinical trials: A moving target. Perspectives in clinical research, 2(4), 124-128.

[19] Bowman, S. (2013). Impact of electronic health record systems on information integrity: quality and safety implications. Perspectives in health information management, 10(Fall), 1c.

[20] Boyer, A. P., Fair, A. M., Joosten, Y. A., Dolor, R. J., Williams, N. A., Sherden, L., ... & Wilkins, C. H. (2018). A multilevel approach to stakeholder engagement in the formulation of a clinical data research network. Medical Care, 56, S22-S26.

[21] Businger, A. C., Fuller, T. E., Schnipper, J. L., Rossetti, S. C., Schnock, K. O., Rozenblum, R., ... & Dykes, P. C. (2020). Lessons learned implementing a complex and innovative patient safety learning laboratory project in a large academic medical center. Journal of the American Medical Informatics Association, 27(2), 301-307.

[22] Chang, A., Schyve, P. M., Croteau, R. J., O’Leary, D. S., & Loeb, J. M. (2005). The JCAHO patient safety event taxonomy: a standardized terminology and classification schema for near misses and adverse events. International Journal for Quality in Health Care, 17(2), 95-105.

[23] Chin, R., & Bairu, M. (Eds.). (2011). Global clinical trials: effective implementation and management. Academic Press.

[24] Curtis, N. J., Foster, J. D., Miskovic, D., Brown, C. S., Hewett, P. J., Abbott, S., ... & Francis, N. K. (2020). Association of surgical skill assessment with clinical outcomes in cancer surgery. JAMA surgery, 155(7), 590-598.

[25] Diani, C. A., Rock, A., & Moll, P. (2017). An evaluation of the effectiveness of a risk-based monitoring approach implemented with clinical trials involving implantable cardiac medical devices. Clinical Trials, 14(6), 575-583.

[26] Doupi, P. (2009). National reporting systems for patient safety incidents: a review of the situation in Europe.

[27] Efferth, T., Saeed, M. E., Mirghani, E., Alim, A., Yassin, Z., Saeed, E., ... & Daak, S. (2017). Integration of phytochemicals and phytotherapy into cancer precision medicine. Oncotarget, 8(30), 50284.

[28] Elebe, O., & Imediegwu, C. C. (2020, January). A predictive analytics framework for customer retention in African retail banking sectors. IRE Journals, 3(7). https://irejournals.com

[29] Elebe, O., & Imediegwu, C. C. (2020, June). Data-driven budget allocation in microfinance: A decision support system for resource-constrained institutions. IRE Journals, 3(12). https://irejournals.com

[30] Elebe, O., & Imediegwu, C. C. (2020, March). Behavioral segmentation for improved mobile banking product uptake in underserved markets. IRE Journals, 3(9). https://irejournals.com

[31] Ellenberg, S. S., Fleming, T. R., & DeMets, D. L. (2019). Data monitoring committees in clinical trials: a practical perspective. John Wiley & Sons.

[32] Eneogu, R. A., Mitchell, E. M., Ogbudebe, C., Aboki, D., Anyebe, V., Dimkpa, C. B., ... & Nongo, D. (2020). Operationalizing Mobile Computer-assisted TB Screening and Diagnosis with Wellness on Wheels (WoW)) in Nigeria: Balancing Feasibility and Iterative Efficiency.

[33] Enna, S. J., & Williams, M. (2009). Defining the role of pharmacology in the emerging world of translational research. In Advances in pharmacology (Vol. 57, pp. 1-30). Academic Press.

[34] Essien, I. A., Cadet, E., Ajayi, J. O., Erigha, E. D., & Obuse, E. (2020). Cyber risk mitigation and incident response model leveraging ISO 27001 and NIST for global enterprises. IRE Journals, 3(7), 379–388.

[35] Essien, I. A., Cadet, E., Ajayi, J. O., Erigha, E. D., & Obuse, E. (2019). Integrated governance, risk, and compliance framework for multi-cloud security and global regulatory alignment. IRE Journals, 3(3), 215–224.

[36] Essien, I. A., Cadet, E., Ajayi, J. O., Erigha, E. D., & Obuse, E. (2020). Regulatory compliance monitoring system for GDPR, HIPAA, and PCI-DSS across distributed cloud architectures. IRE Journals, 3(12), 409–420.

[37] Fenlon, D., Chivers Seymour, K., Okamoto, I., Winter, J., Richardson, A., Addington-Hall, J., ... & Foster, C. (2013). Lessons learnt recruiting to a multi-site UK cohort study to explore recovery of health and well-being after colorectal cancer (CREW study). BMC medical research methodology, 13(1), 153.

[38] Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of clinical trials. springer.

[39] Giwah, M. L., Nwokediegwu, Z. S., Etukudoh, E. A., & Gbabo, E. Y. (2020). A resilient infrastructure financing framework for renewable energy expansion in Sub-Saharan Africa. IRE Journals, 3(12), 382–394. https://www.irejournals.com/paper-details/1709804

[40] Giwah, M. L., Nwokediegwu, Z. S., Etukudoh, E. A., & Gbabo, E. Y. (2020). A systems thinking model for energy policy design in Sub-Saharan Africa. IRE Journals, 3(7), 313–324. https://www.irejournals.com/paper-details/1709803

[41] Giwah, M. L., Nwokediegwu, Z. S., Etukudoh, E. A., & Gbabo, E. Y. (2020). Sustainable energy transition framework for emerging economies: Policy pathways and implementation gaps. International Journal of Multidisciplinary Evolutionary Research, 1(1), 1–6. https://doi.org/10.54660/IJMER.2020.1.1.01-06

[42] Gong, Y., Kang, H., Wu, X., & Hua, L. (2017). Enhancing patient safety event reporting. Applied clinical informatics, 8(03), 893-909.

[43] Goodlett, D., Hung, A., Feriozzi, A., Lu, H., Bekelman, J. E., & Mullins, C. D. (2020). Site engagement for multi-site clinical trials. Contemporary Clinical Trials Communications, 19, 100608.

[44] Hamilton, A. B., & Yano, E. M. (2017). The importance of symbolic and engaged participation in evidence-based quality improvement in a complex integrated healthcare system: response to “The science of stakeholder engagement in research”. Translational behavioral medicine, 7(3), 492-494.

[45] Haw, J. S., Galaviz, K. I., Straus, A. N., Kowalski, A. J., Magee, M. J., Weber, M. B., ... & Ali, M. K. (2017). Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials. JAMA internal medicine, 177(12), 1808-1817.

[46] Hedt-Gauthier, B. L., Chilengi, R., Jackson, E., Michel, C., Napua, M., Odhiambo, J., & Bawah, A. (2017). Research capacity building integrated into PHIT projects: leveraging research and research funding to build national capacity. BMC health services research, 17(Suppl 3), 825.

[47] Hendricks-Ferguson, V. L., Cherven, B. O., Burns, D. S., Docherty, S. L., Phillips-Salimi, C. R., Roll, L., ... & Haase, J. E. (2013). Recruitment strategies and rates of a multi-site behavioral intervention for adolescents and young adults with cancer. Journal of Pediatric Health Care, 27(6), 434-442.

[48] Higa, A., Yagi, M., Hayashi, K., Kosako, M., & Akiho, H. (2020). Risk-based monitoring approach to ensure the quality of clinical study data and enable effective monitoring. Therapeutic Innovation & Regulatory Science, 54(1), 139-143.

[49] Hoffmann, B., & Rohe, J. (2010). Patient safety and error management: what causes adverse events and how can they be prevented?. Deutsches Arzteblatt International, 107(6), 92.

[50] Hopkins, J., Burns, E., & Eden, T. (2013). International twinning partnerships: an effective method of improving diagnosis, treatment and care for children with cancer in low-middle income countries. Journal of Cancer Policy, 1(1-2), e8-e19.

[51] Hungbo, A. Q., & Adeyemi, C. (2019). Laboratory Safety and Diagnostic Reliability Framework for Resource-Constrained Blood Bank Operations.

[52] Hungbo, A. Q., Adeyemi, C., & Ajayi, O. O. (2019). Power BI-Based Clinical Decision Support System for Evidence-Based Nurse Decision-Making.

[53] Hurley, C., Shiely, F., Power, J., Clarke, M., Eustace, J. A., Flanagan, E., & Kearney, P. M. (2016). Risk based monitoring (RBM) tools for clinical trials: a systematic review. Contemporary clinical trials, 51, 15-27.

[54] Imediegwu, C. C., & Elebe, O. (2020, August). KPI integration model for small-scale financial institutions using Microsoft Excel and Power BI. IRE Journals, 4(2). https://irejournals.com

[55] Imediegwu, C. C., & Elebe, O. (2020, December). Optimizing CRM-based sales pipelines: A business process reengineering model. IRE Journals, 4(6). https://irejournals.com10.

[56] Imediegwu, C. C., & Elebe, O. (2020, October). Leveraging process flow mapping to reduce operational redundancy in branch banking networks. IRE Journals, 4(4). https://irejournals.com

[57] Isa, A., & Dem, B. (2014). Integrating Self-Reliance Education Curriculum For Purdah Women In Northern Nigeria: A Panacea For A Lasting Culture Of Peace.

[58] Johnson, M. R., Kenworthy-Heinige, T., Beck, D. J., Asghar, A., Broussard, E. B., Bratcher, K., ... & Planeta, B. M. (2018). Research site mentoring: A novel approach to improving study recruitment. Contemporary clinical trials communications, 9, 172-177.

[59] K Gohagan, J., Brien, B., A Hasson, M., D Umbel, K., Bridgeman, B., S Kramer, B., ... & C Prorok, P. (2015). Comprehensive Quality Management (CQM) in the PLCO Trial. Reviews on Recent Clinical Trials, 10(3), 223-232.

[60] Kent, J., Thornton, M., Fong, A., Hall, E., Fitzgibbons, S., & Sava, J. (2020). Acute provider stress in high stakes medical care: implications for trauma surgeons. Journal of Trauma and Acute Care Surgery, 88(3), 440-445.

[61] Kingsley, O., Akomolafe, O. O., & Akintimehin, O. O. (2020). A Community-Based Health and Nutrition Intervention Framework for Crisis-Affected Regions. Iconic Research and Engineering Journals, 3(8), 311-333.

[62] Lewis, S., Bloom, J., Rice, J., Naeim, A., & Shortell, S. (2014). Using teams to implement personalized health care across a multi-site breast cancer network. In Population Health Management in Health Care Organizations (pp. 71-94). Emerald Group Publishing Limited.

[63] Liu, Y., Nandita, M. D., Shankar, L. K., Kauczor, H. U., Trattnig, S., Collette, S., & Chiti, A. (2015). A risk management approach for imaging biomarker-driven clinical trials in oncology. The Lancet Oncology, 16(16), e622-e628.

[64] López-Hernández, L. B., Díaz, B. G., Zamora González, E. O., Montes-Hernández, K. I., Tlali Díaz, S. S., Toledo-Lozano, C. G., ... & Vázquez Cárdenas, N. A. (2020, December). Quality and safety in healthcare for medical students: challenges and the road ahead. In Healthcare (Vol. 8, No. 4, p. 540). MDPI.

[65] Macefield, R. C., Beswick, A. D., Blazeby, J. M., & Lane, J. A. (2013). A systematic review of on-site monitoring methods for health-care randomised controlled trials. Clinical Trials, 10(1), 104-124.

[66] Menson, W. N. A., Olawepo, J. O., Bruno, T., Gbadamosi, S. O., Nalda, N. F., Anyebe, V., ... & Ezeanolue, E. E. (2018). Reliability of self-reported Mobile phone ownership in rural north-Central Nigeria: cross-sectional study. JMIR mHealth and uHealth, 6(3), e8760.

[67] Middleton, B., Bloomrosen, M., Dente, M. A., Hashmat, B., Koppel, R., Overhage, J. M., ... & Zhang, J. (2013). Enhancing patient safety and quality of care by improving the usability of electronic health record systems: recommendations from AMIA. Journal of the American Medical Informatics Association, 20(e1), e2-e8.

[68] Mugo, C., Njuguna, I., Nduati, M., Omondi, V., Otieno, V., Nyapara, F., ... & Wagner, A. D. (2020). From research to international scale-up: stakeholder engagement essential in successful design, evaluation and implementation of paediatric HIV testing intervention. Health Policy and Planning, 35(9), 1180-1187.

[69] Mustapha, A. Y., Chianumba, E. C., Forkuo, A. Y., Osamika, D., & Komi, L. S. (2018). Systematic Review of Mobile Health (mHealth) Applications for Infectious Disease Surveillance in Developing Countries. Methodology, 66.

[70] Nchinda, T. C. (2002). Research capacity strengthening in the South. Social science & medicine, 54(11), 1699-1711.

[71] Nicholson, K., Ganann, R., Bookey-Bassett, S., Baird, L. G., Garnett, A., Marshall, Z., ... & Stewart, M. (2020). Capacity building and mentorship among pan-Canadian early career researchers in community-based primary health care. Primary health care research & development, 21, e3.

[72] Nsa, B., Anyebe, V., Dimkpa, C., Aboki, D., Egbule, D., Useni, S., & Eneogu, R. (2018, November). Impact of active case finding of tuberculosis among prisoners using the WOW truck in North Central Nigeria. The International Journal of Tuberculosis and Lung Disease, 22(11), S444. The International Union Against Tuberculosis and Lung Disease.

[73] Obodozie, O. O. (2012). Pharmacokinetics and drug interactions of herbal medicines: A missing critical step in the phytomedicine/drug development process. Reading in advanced pharmacokinetics-theory, methods, and applications. Croatia: InTech, 127-56.

[74] Ojika, F. U., Adelusi, B. S., Uzoka, A. C., & Hassan, Y. G. (2020). Leveraging transformer-based large language models for parametric estimation of cost and schedule in agile software development projects. IRE Journals, 4(4), 267–278.

[75] Olaniyan, M. F., Ale, S. A., & Uwaifo, F. (2019). Raw cucumber (Cucumis sativus) fruit juice as possible first-aid antidote in drug-induced toxicity. Recent Adv Biol Med, 5(2019), 10171.

[76] Olaniyan, M. F., Ojediran, T. B., Uwaifo, F., & Azeez, M. M. (2018). Host immune responses to mono-infections of Plasmodium spp., hepatitis B virus, and Mycobacterium tuberculosis as evidenced by blood complement 3, complement 5, tumor necrosis factor-α and interleukin-10: Host immune responses to monoinfections of Plasmodium spp., hepatitis B virus, and Mycobacterium tuberculosis. Community Acquired Infection, 5.

[77] Olaniyan, M. F., Uwaifo, F., & Ojediran, T. B. (2019). Possible viral immunochemical status of children with elevated blood fibrinogen in some herbal homes and hospitals in Nigeria. Environmental Disease, 4(3), 81-86.

[78] Oluyemi, M. D., Akintimehin, O. O., & Akomolafe, O. O. (2020). Designing a Cross-Functional Framework for Compliance with Health Data Protection Laws in Multijurisdictional Healthcare Settings. Iconic Research and Engineering Journals, 4(4), 279-296.

[79] Oluyemi, M. D., Akintimehin, O. O., & Akomolafe, O. O. (2020). Developing a Framework for Data Quality Assurance in Electronic Health Record (EHR) Systems in Healthcare Institutions. Iconic Research and Engineering Journals, 3(12), 335-349.

[80] Oluyemi, M. D., Akintimehin, O. O., & Akomolafe, O. O. (2020). Framework for Leveraging Health Information Systems in Addressing Substance Abuse Among Underserved Populations. Iconic Research and Engineering Journals, 4(2), 212-226.

[81] Oluyemi, M. D., Akintimehin, O. O., & Akomolafe, O. O. (2020). Modeling Health Information Governance Practices for Improved Clinical Decision-Making in Urban Hospitals. Iconic Research and Engineering Journals, 3(9), 350-362.

[82] Oni, O., Adeshina, Y. T., Iloeje, K. F., & Olatunji, O. O. (2018). Artificial Intelligence Model Fairness Auditor For Loan Systems. Journal ID, 8993, 1162.

[83] Onyeji, G. N., & Sanusi, R. A. (2018). Diet quality of women of childbearing age in South-east Nigeria. Nutrition & Food Science, 48(2), 348-364.

[84] Özenver, N., & Efferth, T. (2020). Integration of Phytochemicals and Phytotherapy into Cancer Precision Medicine. In Approaching Complex Diseases: Network-Based Pharmacology and Systems Approach in Bio-Medicine (pp. 355-392). Cham: Springer International Publishing.

[85] Petkovic, J., Riddle, A., Akl, E. A., Khabsa, J., Lytvyn, L., Atwere, P., ... & Tugwell, P. (2020). Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation. Systematic reviews, 9(1), 21.

[86] Pillai, G., Chibale, K., Constable, E. C., Keller, A. N., Gutierrez, M. M., Mirza, F., ... & Kaiser, H. J. (2018). The Next Generation Scientist program: capacity-building for future scientific leaders in low-and middle-income countries. BMC Medical Education, 18(1), 233.

[87] Ponka, D., Coffman, M., Fraser-Barclay, K. E., Fortier, R. D., Howe, A., Kidd, M., ... & Goodyear-Smith, F. (2020). Fostering global primary care research: a capacity-building approach. BMJ global health, 5(7), e002470.

[88] Rosemann, A. (2017). Challenges to international stem cell clinical trials in countries with diverging regulations. In Safety, ethics and regulations (pp. 301-319). Cham: Springer International Publishing.

[89] Roses, A. D. (2008). Pharmacogenetics in drug discovery and development: a translational perspective. Nature reviews Drug discovery, 7(10), 807-817.

[90] Scholten, J., Eneogu, R., Ogbudebe, C., Nsa, B., Anozie, I., Anyebe, V., Lawanson, A., & Mitchell, E. (2018, November). Ending the TB epidemic: Role of active TB case finding using mobile units for early diagnosis of tuberculosis in Nigeria. The International Journal of Tuberculosis and Lung Disease, 22(11), S392. The International Union Against Tuberculosis and Lung Disease.

[91] Selby, J. V., Grossman, C., Zirkle, M., & Barbash, S. (2018). Multistakeholder engagement in PCORnet, the national patient-centered clinical research network. Medical Care, 56, S4-S5.

[92] Shyur, L. F., & Yang, N. S. (2008). Metabolomics for phytomedicine research and drug development. Current opinion in chemical biology, 12(1), 66-71.

[93] Smith, L., Tan, A., Stephens, J. D., Hibler, D., & Duffy, S. A. (2019). Overcoming challenges in multisite trials. Nursing research, 68(3), 227-236.

[94] Taiwo, K. A. 2015: AI in population health: Scaling preventive models for age-related diseases in the United States. International Journal of Science and Research Archive, 2025, 16(01), 1240-1260. https://doi.org/10.30574/ijsra.2025.16.1.2015

[95] Thomford, N. E., Dzobo, K., Chimusa, E., Andrae-Marobela, K., Chirikure, S., Wonkam, A., & Dandara, C. (2018). Personalized herbal medicine? A roadmap for convergence of herbal and precision medicine biomarker innovations. OMICS: A Journal of Integrative Biology, 22(6), 375-391.

[96] Thornicroft, G., Cooper, S., Bortel, T. V., Kakuma, R., & Lund, C. (2012). Capacity building in global mental health research. Harvard review of psychiatry, 20(1), 13-24.

[97] Timmermans, C., Venet, D., & Burzykowski, T. (2016). Data-driven risk identification in phase III clinical trials using central statistical monitoring. International journal of clinical oncology, 21(1), 38-45.

[98] Ulrich-Merzenich, G., Panek, D., Zeitler, H., Wagner, H., & Vetter, H. (2009). New perspectives for synergy research with the “omic”-technologies. Phytomedicine, 16(6-7), 495-508.

[99] Uwaifo, F. (2020). Evaluation of weight and appetite of adult wistar rats supplemented with ethanolic leaf extract of Moringa oleifera. Biomedical and Biotechnology Research Journal (BBRJ), 4(2), 137-140.

[100] Uwaifo, F., & Favour, J. O. (2020). Assessment of the histological changes of the heart and kidneys induced by berberine in adult albino wistar rats. Matrix Science Medica, 4(3), 70-73.

[101] Uwaifo, F., & John-Ohimai, F. (2020). Body weight, organ weight, and appetite evaluation of adult albino Wistar rats treated with berberine. International Journal of Health & Allied Sciences, 9(4), 329-329.

[102] Uwaifo, F., & John-Ohimai, F. (2020). Dangers of organophosphate pesticide exposure to human health. Matrix Science Medica, 4(2), 27-31.

[103] Uwaifo, F., Ngokere, A., Obi, E., Olaniyan, M., & Bankole, O. (2019). Histological and biochemical changes induced by ethanolic leaf extract of Moringa oleifera in the liver and lungs of adult wistar rats. Biomedical and Biotechnology Research Journal (BBRJ), 3(1), 57-60.

[104] Uwaifo, F., Obi, E., Ngokere, A., Olaniyan, M. F., Oladeinde, B. H., & Mudiaga, A. (2018). Histological and biochemical changes induced by ethanolic leaf extract of Moringa oleifera in the heart and kidneys of adult wistar rats. Imam Journal of Applied Sciences, 3(2), 59-62.

[105] Will, Y., McDuffie, J. E., Olaharski, A. J., & Jeffy, B. D. (Eds.). (2016). Drug discovery toxicology: from target assessment to translational biomarkers. John Wiley & Sons.

[106] Zineh, I., & Woodcock, J. (2013). Clinical pharmacology and the catalysis of regulatory science: opportunities for the advancement of drug development and evaluation. Clinical Pharmacology & Therapeutics, 93(6), 515-525.

How to cite this paper

Chisom Ezeanochie, Opeoluwa Oluwanifemi Ajayi, Christiana Adeyemi "Strengthening Patient Safety Protocols Through Data Integrity and Adverse Event Management" Iconic Research And Engineering Journals Volume 3 Issue 8 2020 Page 390-411
Chisom Ezeanochie, Opeoluwa Oluwanifemi Ajayi, Christiana Adeyemi "Strengthening Patient Safety Protocols Through Data Integrity and Adverse Event Management" Iconic Research And Engineering Journals, vol. 3, no. 8, Feb. 2020
Chisom Ezeanochie, Opeoluwa Oluwanifemi Ajayi, Christiana Adeyemi (2020). Strengthening Patient Safety Protocols Through Data Integrity and Adverse Event Management. Iconic Research And Engineering Journals, 3(8).
Chisom Ezeanochie, Opeoluwa Oluwanifemi Ajayi, Christiana Adeyemi "Strengthening Patient Safety Protocols Through Data Integrity and Adverse Event Management" Iconic Research And Engineering Journals, vol. 3, no. 8, Feb. 2020.
@article{1710570,
      author = {Chisom Ezeanochie, Opeoluwa Oluwanifemi Ajayi, Christiana Adeyemi},
      title = {Strengthening Patient Safety Protocols Through Data Integrity and Adverse Event Management},
      journal = {Iconic Research And Engineering Journals},
      year = {2020},
      volume = {3},
      number = {8},
      pages = {390-411},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1710570.pdf},
      abstract = {Patient safety remains a cornerstone of effective healthcare delivery, yet it continues to face significant challenges due to lapses in data integrity and inadequate adverse event management systems. Ensuring accurate, complete, and reliable health data is critical to minimizing medical errors, optimizing clinical decision-making, and safeguarding patient outcomes. This study explores how strengthening patient safety protocols through robust data integrity measures and comprehensive adverse event management frameworks can transform healthcare systems. The paper emphasizes the role of advanced health information technologies, including electronic health records (EHRs), predictive analytics, and artificial intelligence, in enhancing data accuracy, preventing duplication, and ensuring real-time monitoring of patient conditions. By integrating these tools with standardized reporting systems, healthcare organizations can better detect, document, and respond to adverse events such as medication errors, hospital-acquired infections, and surgical complications. The research also highlights the importance of establishing a culture of transparency, continuous learning, and accountability in healthcare institutions, where frontline staff are encouraged to report safety concerns without fear of blame. Furthermore, the paper underscores the need for regulatory compliance with global patient safety frameworks, data protection laws, and interoperability standards to ensure consistency across diverse healthcare settings. Case examples demonstrate how improved data governance and adverse event surveillance can reduce preventable harm, shorten hospital stays, and lower healthcare costs. The findings suggest that a multi-pronged approach combining technology adoption, staff training, policy development, and stakeholder collaboration is essential to strengthening patient safety. Ultimately, advancing data integrity and adverse event management will not only protect patients but also build public trust, support sustainable healthcare delivery, and align with global health priorities such as the World Health Organization?s Patient Safety Action Plan. This work contributes to ongoing discourse on healthcare quality improvement by presenting an integrated framework for safeguarding patients through data-driven safety protocols.},
      keywords = {Patient Safety, Data Integrity, Adverse Event Management, Electronic Health Records, Predictive Analytics, Healthcare Quality, Patient Outcomes, Medical Errors, Data Governance, Risk Management},
      month = {February},
  }